Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

ImmunityBio (IBRX) Interest & Investment Income (2016 - 2021)

ImmunityBio (IBRX) has disclosed Interest & Investment Income for 7 consecutive years, with $112000.0 as the latest value for Q2 2021.

  • Quarterly Interest & Investment Income fell 67.16% to $112000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $10.4 million through Jun 2021, up 806.0% year-over-year, with the annual reading at $1.2 million for FY2020, 24.95% down from the prior year.
  • Interest & Investment Income for Q2 2021 was $112000.0 at ImmunityBio, down from $8.9 million in the prior quarter.
  • The five-year high for Interest & Investment Income was $8.9 million in Q1 2021, with the low at $78000.0 in Q1 2020.
  • Average Interest & Investment Income over 5 years is $1.1 million, with a median of $492500.0 recorded in 2018.
  • The sharpest move saw Interest & Investment Income plummeted 78.92% in 2020, then surged 11366.67% in 2021.
  • Over 5 years, Interest & Investment Income stood at $2.1 million in 2017, then plummeted by 76.26% to $495000.0 in 2018, then crashed by 37.98% to $307000.0 in 2019, then soared by 197.72% to $914000.0 in 2020, then tumbled by 87.75% to $112000.0 in 2021.
  • According to Business Quant data, Interest & Investment Income over the past three periods came in at $112000.0, $8.9 million, and $914000.0 for Q2 2021, Q1 2021, and Q4 2020 respectively.